ARCT
Arcturus Therapeutics Holdings Inc.
Company overview
- Market capitalization
- $411.00M
- Employees
- 106
- Latest publication
- 2026-09-29
About Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In addition, it develops KOSTAIVE, a self-amplifying RNA vaccine for COVID-19; ARCT-2138 (LUNAR-FLU), which is in Phase1 clinical trial for the treatment of seasonal influenza; and ARCT-2304 (LUNAR-H5N1) that is in Phase1 clinical trial for the treatment of Pandemic Influenza. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 610,000USD | 3,081,000USD | 17,151,000USD | 24,510,000USD | 29,382,000USD | 21,000,000USD | 38,815,000USD | 45,976,000USD |
| Cost Of Revenue | 658,000USD | 682,000USD | 3,342,000USD | — | — | 819,000USD | 900,000USD | 900,000USD |
| Gross Profit | -48,000USD | 3,081,000USD | 13,809,000USD | 24,510,000USD | 29,382,000USD | 21,000,000USD | 38,815,000USD | 45,976,000USD |
| Research Development | 20,925,000USD | 24,476,000USD | 23,265,000USD | 29,579,000USD | 34,893,000USD | 43,780,000USD | 39,134,000USD | 58,669,000USD |
| Selling General Administrative | 9,465,000USD | 14,027,000USD | 10,398,000USD | 10,338,000USD | 11,315,000USD | 12,380,000USD | 13,276,000USD | 12,316,000USD |
| Total Operating Expenses | 29,732,000USD | 34,388,000USD | 30,321,000USD | 36,126,000USD | 46,208,000USD | 54,394,000USD | 49,552,000USD | 67,102,000USD |
| Operating Income | -29,780,000USD | -31,307,000USD | -16,512,000USD | -11,616,000USD | -16,826,000USD | -33,394,000USD | -10,737,000USD | -21,126,000USD |
| Interest Income | 1,932,000USD | 1,532,000USD | 3,234,000USD | 2,567,000USD | 2,771,000USD | 8,767,000USD | 7,636,000USD | 4,148,000USD |
| Net Interest Income | 1,932,000USD | 1,523,000USD | 3,234,000USD | 2,567,000USD | 2,771,000USD | -8,767,000USD | 7,636,000USD | 4,148,000USD |
| Income Before Tax | -26,964,000USD | -29,083,000USD | -13,448,000USD | -9,176,000USD | -14,076,000USD | -30,009,000USD | -7,120,000USD | -17,366,000USD |
| Net Income | -26,964,000USD | -29,079,000USD | -13,448,000USD | -9,180,000USD | -14,076,000USD | -30,005,000USD | -6,903,000USD | -17,216,000USD |
| Net Income From Continuing Ops | -26,964,000USD | -29,079,000USD | -13,448,000USD | -9,180,000USD | -14,076,000USD | -30,005,000USD | -6,903,000USD | -17,216,000USD |
| Ebit | -29,780,000USD | -20,821,000USD | -13,448,000USD | -11,616,000USD | -16,826,000USD | -30,009,000USD | -7,120,000USD | -21,126,000USD |
| Ebitda | -29,122,000USD | -20,139,000USD | -12,685,000USD | -10,837,000USD | -16,025,000USD | -29,190,000USD | -6,208,000USD | -20,217,000USD |
| Depreciation And Amortization | 658,000USD | 682,000USD | 763,000USD | 779,000USD | 801,000USD | 819,000USD | 912,000USD | 909,000USD |
| Reconciled Depreciation | 658,000USD | 682,000USD | 763,000USD | 779,000USD | 801,000USD | 819,000USD | 912,000USD | 909,000USD |
| Total Other Income Expense Net | 2,816,000USD | 2,224,000USD | 3,064,000USD | 2,440,000USD | 2,750,000USD | 3,385,000USD | 3,617,000USD | 3,760,000USD |
| Unclassified Operating Expenses | — | -4,115,000USD | -3,342,000USD | -3,791,000USD | — | -1,766,000USD | -2,858,000USD | -3,883,000USD |
| Income Tax Expense | — | -4,000USD | -16,682,000USD | 4,000USD | -16,847,000USD | -4,000USD | -217,000USD | -150,000USD |
| Tax Provision | — | -4,000USD | 0USD | 4,000USD | 0USD | -4,000USD | -217,000USD | -150,000USD |
| Interest Expense | — | — | — | — | — | 0USD | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 67,221,000USD | 138,389,000USD | 157,748,000USD | 205,755,000USD | 12,359,000USD | 9,539,000USD | 20,789,000USD | 15,753,000USD |
| Cost Of Revenue | 3,025,000USD | 3,544,000USD | 2,957,000USD | 143,051,000USD | 173,760,000USD | 55,946,000USD | 32,440,000USD | 16,982,000USD |
| Gross Profit | 64,196,000USD | 138,389,000USD | 157,748,000USD | 205,755,000USD | 12,359,000USD | -46,407,000USD | 20,789,000USD | -1,229,000USD |
| Research Development | 112,212,000USD | 195,156,000USD | 192,133,000USD | 147,751,000USD | 173,760,000USD | 57,846,000USD | 33,640,000USD | 16,982,000USD |
| Selling General Administrative | 46,079,000USD | 52,823,000USD | 52,871,000USD | 46,071,000USD | 41,451,000USD | 23,217,000USD | 12,662,000USD | 20,582,000USD |
| Unclassified Operating Expenses | -19,140,000USD | -13,921,000USD | -9,051,000USD | — | — | -55,946,000USD | — | — |
| Total Operating Expenses | 139,151,000USD | 234,058,000USD | 235,953,000USD | 193,578,000USD | 215,211,000USD | 25,117,000USD | 46,302,000USD | 37,564,000USD |
| Operating Income | -74,955,000USD | -95,669,000USD | -78,205,000USD | 12,177,000USD | -202,852,000USD | -71,524,000USD | -25,513,000USD | -21,811,000USD |
| Interest Income | 10,104,000USD | 15,195,000USD | 12,288,000USD | 2,581,000USD | 753,000USD | 470,000USD | 408,000USD | 514,000USD |
| Interest Expense | 9,000USD | 0USD | 767,000USD | 3,001,000USD | 2,674,000USD | 831,000USD | 854,000USD | 186,000USD |
| Net Interest Income | 10,095,000USD | 15,195,000USD | 10,735,000USD | -420,000USD | -1,921,000USD | -361,000USD | -446,000USD | 328,000USD |
| Income Before Tax | -65,783,000USD | -80,945,000USD | -27,890,000USD | 10,644,000USD | -203,674,000USD | -72,148,000USD | -25,991,000USD | -21,785,000USD |
| Income Tax Expense | -75,878,000USD | -4,000USD | 1,835,000USD | 1,295,000USD | 3,189,000USD | -784,000USD | -270,000USD | 212,000USD |
| Tax Provision | 0USD | -4,000USD | 2,868,000USD | 1,295,000USD | 0USD | — | — | 0USD |
| Net Income | -65,783,000USD | -80,941,000USD | -29,725,000USD | 9,349,000USD | -203,674,000USD | -72,148,000USD | -25,991,000USD | -21,785,000USD |
| Net Income From Continuing Ops | -65,783,000USD | -80,941,000USD | 99,329,000USD | 9,349,000USD | -203,674,000USD | -72,148,000USD | -25,991,000USD | -21,785,000USD |
| Ebit | -74,955,000USD | -80,945,000USD | -27,122,000USD | 12,177,000USD | -202,852,000USD | -71,524,000USD | -25,137,000USD | -21,297,000USD |
| Ebitda | -71,930,000USD | -77,401,000USD | -24,165,000USD | 13,704,000USD | -201,659,000USD | -70,642,000USD | -24,453,000USD | -20,715,000USD |
| Depreciation And Amortization | 3,025,000USD | 3,544,000USD | 2,957,000USD | 1,527,000USD | 1,193,000USD | 882,000USD | 684,000USD | 582,000USD |
| Reconciled Depreciation | 3,025,000USD | 3,544,000USD | 2,693,000USD | 1,527,000USD | 1,193,000USD | 882,000USD | 684,000USD | 582,000USD |
| Total Other Income Expense Net | 9,172,000USD | 14,724,000USD | 50,315,000USD | -1,533,000USD | -822,000USD | -624,000USD | -478,000USD | 26,000USD |
| Net Income Applicable To Common Shares | — | — | — | 9,349,000USD | -203,674,000USD | -72,148,000USD | -25,991,000USD | -21,785,000USD |
| Non Operating Income Net Other | — | — | — | — | -822,000USD | -624,000USD | -478,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 245,411,000USD | 271,148,000USD | 282,343,000USD | 309,270,000USD | 331,785,000USD | 344,069,000USD | 370,654,000USD | 388,608,000USD |
| Other Current Assets | 4,164,000USD | 4,973,000USD | 60,889,000USD | 60,832,000USD | 47,274,000USD | 64,977,000USD | 63,444,000USD | 7,594,000USD |
| Total Liab | 54,049,000USD | 57,163,000USD | 57,784,000USD | 78,217,000USD | 98,026,000USD | 103,091,000USD | 108,788,000USD | 130,025,000USD |
| Total Stockholder Equity | 191,362,000USD | 213,985,000USD | 224,559,000USD | 231,053,000USD | 233,759,000USD | 240,978,000USD | 261,866,000USD | 258,583,000USD |
| Other Current Liab | 22,666,000USD | 19,684,000USD | 19,382,000USD | 31,861,000USD | 39,559,000USD | 32,808,000USD | 55,897,000USD | 29,019,000USD |
| Common Stock | 28,000USD | 28,000USD | 27,000USD | 27,000USD | 27,000USD | 27,000USD | 27,000USD | 27,000USD |
| Capital Stock | 28,000USD | 28,000USD | 27,000USD | 27,000USD | 27,000USD | 27,000USD | 27,000USD | 27,000USD |
| Retained Earnings | -541,554,000USD | -514,590,000USD | -485,511,000USD | -472,063,000USD | -462,883,000USD | -448,807,000USD | -418,802,000USD | -411,899,000USD |
| Cash | 211,375,000USD | 230,909,000USD | 180,360,000USD | 196,467,000USD | 216,948,000USD | 237,028,000USD | 237,178,000USD | 315,329,000USD |
| Cash And Short Term Investments | 211,375,000USD | 230,909,000USD | 180,360,000USD | 196,467,000USD | 216,948,000USD | 237,028,000USD | 237,178,000USD | 315,329,000USD |
| Total Current Assets | 216,882,000USD | 241,446,000USD | 249,200,000USD | 274,503,000USD | 278,794,000USD | 305,979,000USD | 330,821,000USD | 347,008,000USD |
| Total Current Liabilities | 34,369,000USD | 36,379,000USD | 31,699,000USD | 46,515,000USD | 49,409,000USD | 65,489,000USD | 69,463,000USD | 91,717,000USD |
| Current Deferred Revenue | 7,610,000USD | 8,246,000USD | 6,826,000USD | 11,263,000USD | 15,092,000USD | 21,935,000USD | 26,936,000USD | 44,876,000USD |
| Net Debt | -191,695,000USD | -205,911,000USD | -158,495,000USD | -169,503,000USD | -174,290,000USD | -208,478,000USD | -207,756,000USD | -284,448,000USD |
| Short Long Term Debt Total | 19,680,000USD | 24,998,000USD | 21,865,000USD | 26,963,999USD | 42,658,000USD | 28,550,000USD | 29,422,000USD | 30,881,000USD |
| Net Receivables | 1,343,000USD | 5,564,000USD | 7,951,000USD | 17,204,000USD | 14,572,000USD | 3,974,000USD | 30,199,000USD | 24,085,000USD |
| Accounts Payable | 4,093,000USD | 4,235,000USD | 5,491,000USD | 10,623,000USD | 6,179,000USD | 7,194,000USD | 10,131,000USD | 13,905,000USD |
| Property Plant Equipment Net | 26,501,000USD | 27,817,000USD | 31,258,000USD | 32,881,999USD | 34,606,000USD | 36,205,000USD | 37,948,000USD | 39,715,000USD |
| Property Plant Equipment Gross | 39,440,000USD | 40,308,000USD | 43,229,000USD | 46,273,000USD | 47,218,000USD | 48,016,000USD | 48,940,000USD | 49,795,000USD |
| Common Stock Shares Outstanding | 28,421,000shares | 27,386,000shares | 27,188,000shares | 27,129,000shares | 27,107,000shares | 27,000,000shares | 27,062,000shares | 26,967,000shares |
| Non Current Assets Total | 28,529,000USD | 29,702,000USD | 33,143,000USD | 34,767,000USD | 52,991,000USD | 38,090,000USD | 39,833,000USD | 41,600,000USD |
| Non Current Liabilities Total | 19,680,000USD | 20,784,000USD | 26,085,000USD | 31,702,000USD | 48,617,000USD | 37,602,000USD | 39,325,000USD | 38,308,000USD |
| Non Currrent Assets Other | 2,028,000USD | 1,885,000USD | 1,885,000USD | 1,885,000USD | 18,385,000USD | 1,885,000USD | 1,885,000USD | 1,885,000USD |
| Net Working Capital | 182,513,000USD | 205,067,000USD | 217,501,000USD | 227,988,000USD | 229,385,000USD | 240,490,000USD | 261,358,000USD | 255,291,000USD |
| Unclassified Non Current Liabilities | 19,680,000USD | 20,784,000USD | 26,085,000USD | 31,702,000USD | 33,617,000USD | 37,602,000USD | 39,325,000USD | 38,308,000USD |
| Unclassified Equity | 732,860,000USD | 728,519,000USD | 710,016,000USD | 703,062,000USD | 696,588,000USD | 689,731,000USD | 680,614,000USD | 670,428,000USD |
| Short Term Debt | — | 4,214,000USD | — | 4,030,999USD | 3,671,000USD | 3,552,000USD | 3,435,000USD | 3,917,000USD |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | 0USD | — | 0USD | — |
| Unclassified Current Liabilities | — | — | — | -11,262,999USD | -15,092,000USD | — | -26,936,000USD | — |
| Long Term Debt | — | — | — | — | 15,000,000USD | — | — | — |
| Inventory | — | — | — | — | — | — | — | 1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 271,148,000USD | 344,069,000USD | 429,402,000USD | 450,387,000USD | 392,814,000USD | 476,456,000USD | 82,143,000USD | 44,198,000USD |
| Other Current Assets | 4,973,000USD | 64,977,000USD | 62,521,000USD | 8,686,000USD | 5,102,000USD | 2,769,000USD | 758,000USD | 638,000USD |
| Total Liab | 57,163,000USD | 103,091,000USD | 150,889,000USD | 180,075,000USD | 164,603,000USD | 79,903,000USD | 56,351,000USD | 30,556,000USD |
| Total Stockholder Equity | 213,985,000USD | 240,978,000USD | 278,513,000USD | 270,312,000USD | 228,211,000USD | 396,553,000USD | 25,792,000USD | 13,642,000USD |
| Other Current Liab | 19,684,000USD | 32,808,000USD | 24,417,000USD | 17,585,000USD | 65,468,000USD | 35,867,000USD | 14,704,000USD | 10,179,000USD |
| Common Stock | 28,000USD | 27,000USD | 27,000USD | 27,000USD | 26,000USD | 26,000USD | 15,000USD | 214,000USD |
| Capital Stock | 28,000USD | 27,000USD | 27,000USD | 27,000USD | 26,000USD | 26,000USD | 15,000USD | 214,000USD |
| Retained Earnings | -514,590,000USD | -448,807,000USD | -367,866,000USD | -338,141,000USD | -347,490,000USD | -143,816,000USD | -71,668,000USD | -44,874,000USD |
| Cash | 230,909,000USD | 237,028,000USD | 292,005,000USD | 391,883,000USD | 370,492,000USD | 462,895,000USD | 71,353,000USD | 36,709,000USD |
| Cash And Short Term Investments | 230,909,000USD | 237,028,000USD | 292,005,000USD | 391,883,000USD | 370,492,000USD | 462,895,000USD | 71,353,000USD | 36,709,000USD |
| Total Current Assets | 241,446,000USD | 305,979,000USD | 386,590,000USD | 403,333,000USD | 378,961,000USD | 467,789,000USD | 74,290,000USD | 41,828,000USD |
| Total Current Liabilities | 36,379,000USD | 65,489,000USD | 81,989,000USD | 126,984,000USD | 99,537,000USD | 49,521,000USD | 21,324,000USD | 12,577,000USD |
| Current Deferred Revenue | 8,246,000USD | 21,935,000USD | 47,343,000USD | 36,116,000USD | 43,482,000USD | 18,108,000USD | 8,397,000USD | 6,272,000USD |
| Net Debt | -205,911,000USD | -208,478,000USD | -261,789,000USD | -297,128,000USD | -301,346,000USD | -442,145,000USD | -50,681,000USD | -26,798,000USD |
| Short Term Debt | 4,214,000USD | 3,552,000USD | 4,309,000USD | 64,539,000USD | 24,011,000USD | 2,880,000USD | 827,000USD | — |
| Short Long Term Debt Total | 24,998,000USD | 28,550,000USD | 30,216,000USD | 94,755,000USD | 69,146,000USD | 20,750,000USD | 20,672,000USD | 9,911,000USD |
| Net Receivables | 5,564,000USD | 3,974,000USD | 32,064,000USD | 2,764,000USD | 3,367,000USD | 2,125,000USD | 2,179,000USD | 4,481,000USD |
| Accounts Payable | 4,235,000USD | 7,194,000USD | 5,279,000USD | 7,449,000USD | 10,058,000USD | 10,774,000USD | 5,793,000USD | 2,398,000USD |
| Property Plant Equipment Net | 27,817,000USD | 36,205,000USD | 40,927,000USD | 44,960,000USD | 11,261,000USD | 8,560,000USD | 7,483,000USD | 1,975,000USD |
| Property Plant Equipment Gross | 40,308,000USD | 48,016,000USD | 49,667,000USD | 44,960,000USD | 11,261,000USD | 8,560,000USD | 7,483,000USD | 1,975,000USD |
| Common Stock Shares Outstanding | 27,386,000shares | 27,000,000shares | 26,628,000shares | 27,093,000shares | 26,317,000shares | 20,305,000shares | 12,069,000shares | 10,069,000shares |
| Non Current Assets Total | 29,702,000USD | 38,090,000USD | 42,812,000USD | 47,054,000USD | 13,853,000USD | 8,667,000USD | 7,853,000USD | 2,370,000USD |
| Non Current Liabilities Total | 20,784,000USD | 37,602,000USD | 68,900,000USD | 53,091,000USD | 65,066,000USD | 30,382,000USD | 35,027,000USD | 17,979,000USD |
| Non Currrent Assets Other | 1,885,000USD | 1,885,000USD | 1,885,000USD | 2,094,000USD | 2,077,000USD | 107,000USD | 107,000USD | 107,000USD |
| Net Working Capital | 205,067,000USD | 240,490,000USD | 304,601,000USD | 276,349,000USD | 279,424,000USD | 418,268,000USD | 52,966,000USD | 29,251,000USD |
| Unclassified Non Current Liabilities | 20,784,000USD | 37,602,000USD | 68,403,000USD | 27,412,000USD | -19,931,000USD | -12,512,000USD | -15,182,000USD | — |
| Unclassified Equity | 728,519,000USD | 689,731,000USD | 646,325,000USD | 608,399,000USD | 575,649,000USD | 540,317,000USD | 97,430,000USD | 59,585,000USD |
| Inventory | — | — | -7,521,000USD | — | 1USD | — | — | 1USD |
| Non Current Liabilities Other | — | — | 497,000USD | 2,804,000USD | 4,502,000USD | 4,025,000USD | 4,850,000USD | — |
| Other Liab | — | — | — | 22,875,000USD | 19,931,000USD | 12,512,000USD | 15,182,000USD | 8,068,000USD |
| Short Long Term Debt | — | — | — | 60,655,000USD | 22,474,000USD | 1,250,000USD | — | — |
| Long Term Investments | — | — | — | 0USD | 515,000USD | 0USD | 263,000USD | 288,000USD |
| Unclassified Current Liabilities | — | — | — | -59,360,000USD | -65,956,000USD | -19,358,000USD | -8,397,000USD | -6,272,000USD |
| Deferred Long Term Liab | — | — | — | — | 19,931,000USD | 12,512,000USD | 15,182,000USD | — |
| Other Assets | — | — | — | — | 2,077,000USD | 5,289,000USD | 107,000USD | 107,000USD |
| Long Term Debt | — | — | — | — | 40,633,000USD | 13,845,000USD | 14,995,000USD | 9,911,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | 0USD | 0USD | 0USD | -1,497,000USD |
| Net Tangible Assets | — | — | — | — | 228,211,000USD | 396,553,000USD | 25,792,000USD | 13,642,000USD |
| Unclassified Non Current Assets | — | — | — | — | -2,077,000USD | -5,289,000USD | — | — |
| Short Term Investments | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -26,964,000USD | -29,079,000USD | -13,448,000USD | -9,180,000USD | -14,076,000USD | -30,005,000USD | -6,903,000USD | -17,216,000USD |
| Depreciation | 658,000USD | 682,000USD | 763,000USD | 779,000USD | 801,000USD | 819,000USD | 912,000USD | 909,000USD |
| Stock Based Compensation | 4,325,000USD | 6,817,000USD | 5,729,000USD | 6,200,000USD | 6,662,000USD | 8,983,000USD | 9,493,000USD | 9,424,000USD |
| Other Non Cash Items | -33,000USD | 2,392,580USD | -13,861,000USD | 2,303,000USD | 21,000USD | -172,000USD | 202,000USD | 388,000USD |
| Change To Account Receivables | 4,221,000USD | 2,472,062USD | 9,253,000USD | -2,632,000USD | -10,598,000USD | 26,225,000USD | -6,114,000USD | 2,972,000USD |
| Change In Working Capital | 2,573,000USD | 2,960,420USD | 3,666,000USD | -5,857,000USD | -28,546,000USD | 20,091,000USD | -27,468,000USD | -23,647,000USD |
| Total Cash From Operating Activities | -19,441,000USD | -16,227,000USD | -17,151,000USD | -5,755,000USD | -35,138,000USD | -284,000USD | -23,764,000USD | -30,142,000USD |
| Capital Expenditures | 0USD | -137,660USD | -181,000USD | 0USD | -137,000USD | -2,449USD | -80,000USD | -328,000USD |
| Free Cash Flow | -19,441,000USD | -16,364,660USD | -17,332,000USD | -5,755,000USD | -35,275,000USD | -284,000USD | -23,844,000USD | -30,470,000USD |
| Total Cashflows From Investing Activities | 34,000USD | 87,340USD | -181,000USD | -660USD | -137,000USD | -2,447USD | -80,000USD | -328,000USD |
| Net Borrowings | 0USD | 0USD | 0USD | -15,000,000USD | 15,000,000USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | 16,000USD | 11,688,000USD | 1,225,000USD | -14,726,000USD | 15,195,000USD | 134,000USD | 693,000USD | 2,403,000USD |
| Change In Cash | -19,391,000USD | -4,451,000USD | -16,107,000USD | -20,481,000USD | -20,080,000USD | -150,000USD | -23,151,000USD | -28,067,000USD |
| Begin Period Cash Flow | 232,794,000USD | 237,245,000USD | 253,352,000USD | 273,833,000USD | 293,913,000USD | 294,063,000USD | 317,214,000USD | 345,281,000USD |
| End Period Cash Flow | 213,403,000USD | 232,794,000USD | 237,245,000USD | 253,352,000USD | 273,833,000USD | 293,913,000USD | 294,063,000USD | 317,214,000USD |
| Other Cashflows From Investing Activities | 34,000USD | 225,000USD | -318,000USD | — | -137,000USD | — | -643,345USD | -4,655USD |
| Other Cashflows From Financing Activities | 16,000USD | -733,676USD | 1,225,000USD | -14,726,000USD | 195,000USD | 134,000USD | 693,000USD | 2,403,000USD |
| Issuance Of Capital Stock | — | 11,688,000USD | — | — | — | 0USD | — | — |
| Investments | — | — | -181,000USD | 0USD | -137,000USD | 0USD | -80,000USD | -328,000USD |
| Unclassified Financing Cash Flow | — | — | — | 15,000,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -65,783,000USD | -80,941,000USD | -29,725,000USD | 9,349,000USD | -203,674,000USD | -72,148,000USD | -25,991,000USD | -21,785,000USD |
| Depreciation | 3,025,000USD | 3,544,000USD | 2,957,000USD | 1,527,000USD | 1,193,000USD | 882,000USD | 684,000USD | 582,000USD |
| Stock Based Compensation | 25,408,000USD | 37,988,000USD | 34,649,000USD | 30,611,000USD | 28,915,000USD | 6,764,000USD | 1,982,000USD | 1,259,000USD |
| Other Non Cash Items | 2,279,000USD | 471,000USD | -33,361,000USD | 3,063,000USD | 5,898,000USD | 425,000USD | 873,000USD | 38,000USD |
| Change To Account Receivables | -1,590,000USD | 28,090,000USD | -29,300,000USD | 603,000USD | -1,242,000USD | 54,000USD | 2,302,000USD | -4,001,000USD |
| Change In Working Capital | -39,200,000USD | -20,809,000USD | 7,381,000USD | -12,557,000USD | 32,625,000USD | 21,216,000USD | 15,982,000USD | -1,156,000USD |
| Total Cash From Operating Activities | -74,271,000USD | -59,747,000USD | -18,099,000USD | 31,993,000USD | -135,043,000USD | -42,861,000USD | -6,445,000USD | -20,760,000USD |
| Capital Expenditures | -230,000USD | -648,000USD | -2,901,000USD | -7,726,000USD | -3,406,000USD | -1,742,000USD | -818,000USD | -1,478,000USD |
| Free Cash Flow | -74,271,000USD | -60,395,000USD | -21,000,000USD | 24,267,000USD | -138,449,000USD | -44,603,000USD | -7,263,000USD | -22,238,000USD |
| Total Cashflows From Investing Activities | -230,000USD | -648,000USD | -2,901,000USD | -7,726,000USD | -3,406,000USD | -1,742,000USD | -818,000USD | 22,134,000USD |
| Net Borrowings | 0USD | 0USD | -27,364,000USD | -5,000,000USD | 46,599,000USD | 46,599,000USD | 4,945,000USD | 9,872,000USD |
| Total Cash From Financing Activities | 13,382,000USD | 5,418,000USD | -24,087,000USD | -2,859,000USD | 48,016,000USD | 436,145,000USD | 41,907,000USD | 10,204,000USD |
| Issuance Of Capital Stock | 12,273,000USD | 682,000USD | 609,000USD | 411,000USD | 515,000USD | 423,819,000USD | 36,823,000USD | 0USD |
| Change In Cash | -61,119,000USD | -54,977,000USD | -45,087,000USD | 21,408,000USD | -90,433,000USD | 391,542,000USD | 34,644,000USD | 11,578,000USD |
| Begin Period Cash Flow | 293,913,000USD | 348,890,000USD | 393,977,000USD | 372,569,000USD | 463,002,000USD | 71,460,000USD | 36,816,000USD | 25,238,000USD |
| End Period Cash Flow | 232,794,000USD | 293,913,000USD | 348,890,000USD | 393,977,000USD | 372,569,000USD | 463,002,000USD | 71,460,000USD | 36,816,000USD |
| Other Cashflows From Investing Activities | -230,000USD | -648,000USD | — | -8,299,000USD | -3,459,000USD | -1,742,000USD | -1,058,000USD | 23,612,000USD |
| Other Cashflows From Financing Activities | 13,382,000USD | 4,736,000USD | 2,668,000USD | 1,730,000USD | 902,000USD | 12,326,000USD | 15,684,000USD | 332,000USD |
| Unclassified Financing Cash Flow | -12,273,000USD | — | — | — | — | -49,325,000USD | -15,684,000USD | — |
| Investments | — | -648,000USD | -5,833,000USD | -7,726,000USD | -3,406,000USD | -1,742,000USD | -818,000USD | 22,134,000USD |
| Unclassified Investing Cash Flow | — | 1,296,000USD | 5,833,000USD | 16,025,000USD | 6,865,000USD | 3,484,000USD | 1,876,000USD | -22,134,000USD |
| Change To Liabilities | — | — | — | 0USD | 32,025,000USD | 16,132,000USD | 4,830,000USD | 737,000USD |
| Change To Inventory | — | — | — | — | 450,000USD | 9,309,000USD | 1,555,000USD | 2,108,000USD |
| Sale Purchase Of Stock | — | — | — | — | 1,417,000USD | 426,545,000USD | 36,962,000USD | 332,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | -90,433,000USD | 391,542,000USD | 34,644,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Collaboration Revenue | 610,000 | USD | 0001193125-26-211943 |
| Q1 2026Quarterly · 2026-03-31 | Product | Grant | 1,451,000 | USD | 0001193125-26-211943 |
| Q4 2025Quarterly · 2025-12-31 | Product | Collaboration Revenue | 3,081,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Grant | 4,116,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Collaboration Revenue | 67,221,000 | USD | 0001193125-26-088391 |
| FY 2025Yearly · 2025-12-31 | Product | Grant | 14,810,000 | USD | 0001193125-26-088391 |
| Q3 2025Quarterly · 2025-09-30 | Product | Collaboration Revenue | 14,153,000 | USD | 0001193125-25-275758 |
| Q3 2025Quarterly · 2025-09-30 | Product | Grant | 2,998,000 | USD | 0001193125-25-275758 |
| Q2 2025Quarterly · 2025-06-30 | Product | Collaboration Revenue | 24,510,000 | USD | 0000950170-25-106560 |
| Q2 2025Quarterly · 2025-06-30 | Product | Grant | 3,791,000 | USD | 0000950170-25-106560 |
| Q1 2025Quarterly · 2025-03-31 | Product | Collaboration Revenue | 25,477,000 | USD | 0001193125-26-211943 |
| Q1 2025Quarterly · 2025-03-31 | Product | Grant | 3,905,000 | USD | 0001193125-26-211943 |
| Q4 2024Quarterly · 2024-12-31 | Product | Collaboration Revenue | 21,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Grant | 1,766,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Collaboration Revenue | 138,389,000 | USD | 0001193125-26-088391 |
| FY 2024Yearly · 2024-12-31 | Product | Grant | 13,921,000 | USD | 0001193125-26-088391 |
| Q3 2024Quarterly · 2024-09-30 | Product | Collaboration Revenue | 38,815,000 | USD | 0001193125-25-275758 |
| Q3 2024Quarterly · 2024-09-30 | Product | Grant | 2,858,000 | USD | 0001193125-25-275758 |
| Q2 2024Quarterly · 2024-06-30 | Product | Collaboration Revenue | 45,976,000 | USD | 0000950170-25-106560 |
| Q2 2024Quarterly · 2024-06-30 | Product | Grant | 3,883,000 | USD | 0000950170-25-106560 |
| FY 2023Yearly · 2023-12-31 | Product | Collaboration Revenue | 157,748,000 | USD | 0001193125-26-088391 |
| FY 2023Yearly · 2023-12-31 | Product | Grant | 9,051,000 | USD | 0001193125-26-088391 |
| FY 2022Yearly · 2022-12-31 | Product | Collaboration Revenue | 205,755,000 | USD | 0000950170-25-034787 |
| FY 2022Yearly · 2022-12-31 | Product | Grant | 244,000 | USD | 0000950170-25-034787 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.